# OnCo record da-paper-clarity-ad (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/da-paper-clarity-ad/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "da-paper-clarity-ad" ;
  schema:name "Lecanemab in Early Alzheimer’s Disease (CLARITY AD)"@en ;
  schema:description "The published CLARITY AD paper reports the phase 3 lecanemab trial in early Alzheimer’s disease. Read the paper and the FDA communication together."@en ;
  schema:url <https://onco.cc/key-papers/da-paper-clarity-ad/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2212948>, <https://clinicaltrials.gov/study/NCT03887455> ;
  onco:tag "dementia-atlas" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2212948> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "van Dyck CH, et al." ;
  onco:cancers <https://onco.cc/diagnoses/alzheimers-disease/> ;
  onco:drugs <https://onco.cc/drugs/da-lecanemab/> ;
  onco:trials <https://onco.cc/trials/da-trial-clarity-ad/> ;
  onco:journals <https://onco.cc/journals/da-journal-nejm/> .